Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMen starting Mounjaro (tirzepatide) experience the same broad side-effect profile as anyone else on the medicine — mostly gastrointestinal, most noticeable in the first few weeks, and usually manageable. That said, a few questions come up specifically for male patients: effects on energy, muscle loss, and what to watch for as doses increase. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before treatment starts. This page covers what the clinical evidence and NHS guidance on tirzepatide tell us, honestly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You're a few injections into Mounjaro and the nausea has been more pronounced than you expected. Your appetite has fallen sharply, you're eating less, and you're not sure whether the tiredness you feel is the medicine or just the lower calorie intake catching up with you. That uncertainty is common, and it's worth naming: most men who contact their prescriber in the first month aren't reporting a serious problem — they're adjusting to a drug that actively changes how full and hungry they feel.
The side-effect pattern for tirzepatide in male patients follows what clinical trial data shows for the general population. Nausea is the most frequently reported symptom, followed by diarrhoea, constipation, vomiting, indigestion, and burping. Fatigue and headaches appear too, usually in the first couple of weeks at a new dose. Mounjaro's broader side-effect profile is well-documented; the male-specific questions tend to centre on body composition, energy, and (occasionally) libido, though the last of these is not a recognised direct effect of tirzepatide. It's also worth knowing that Mounjaro side effects in females can differ in pattern and presentation, which helps explain why the male experience sometimes feels underrepresented in general guidance.
One thing worth knowing: symptoms typically peak in the days immediately after an injection and ease as the week goes on. If that pattern holds, it's usually a sign of normal adjustment. If symptoms are severe, persistent, or getting worse across injections rather than better, that's a different matter and warrants a call to your prescriber or, if the pain is acute, urgent medical help.
This is the question our prescribers hear most often from male patients: will I lose muscle? The short answer is yes, some loss of lean mass is possible during significant calorie reduction, and Mounjaro does reduce calorie intake substantially. In the SURMOUNT-1 trial, participants lost an average of around 20% of their body weight at the highest dose, and body-composition analyses consistently show that some of that reduction is lean mass, not just fat. The proportion varies by individual, activity level, and protein intake.
The practical response is well-established: prioritise protein at every meal (aiming for adequate daily intake rather than a fixed number, since targets vary by body weight and activity), keep resistance training in your routine, and don't cut calories so aggressively that you're consistently under your protein needs. These aren't unique to tirzepatide, they're sound principles during any period of rapid weight loss.
Fatigue during the early weeks can make training feel harder than usual. That's real, and it usually settles. Some people also find that tolerating Mounjaro with no side effects is genuinely possible, particularly those who titrate slowly and keep protein intake consistent, so if your experience improves markedly it isn't something to second-guess. If low energy persists beyond the first month, raise it with your prescriber; it can occasionally reflect inadequate calorie or micronutrient intake rather than a direct drug effect. The five side effects men most commonly ask about covers this in more detail, including practical strategies for the adjustment phase.
Most side effects on Mounjaro are uncomfortable rather than dangerous. Some are not. Knowing which is which matters, and the NHS is clear on the signs that need prompt attention.
Get urgent medical help if you experience severe stomach pain that doesn't ease, particularly if it spreads to your back or comes with vomiting. This may indicate acute pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Don't wait to see if it passes. Similarly, signs of a serious allergic reaction (facial or throat swelling, difficulty breathing, a widespread rash) need emergency attention.
Gallbladder problems (pain in the upper-right abdomen, particularly after eating) are also recognised with this class of medicine. Dehydration from severe vomiting or diarrhoea can become significant quickly, especially if you're also exercising; if you can't keep fluids down for more than a day, seek medical advice. Questions sometimes arise about less obvious physical changes too, and if you're wondering whether Mounjaro causes hair loss, that page sets out what the evidence currently shows. The MHRA Drug Safety Updates page carries the full January 2026 bulletin on GLP-1 medicines and pancreatitis if you want to read it directly.
For everything short of those red-flag symptoms, the right first call is your prescriber. At nume, our support team is available seven days a week for exactly this kind of question. You're not expected to manage adjustments alone.
Mounjaro is a prescription-only medicine, and that's not a bureaucratic detail. The initial assessment exists so that a prescriber can weigh your specific health history against the known risks, pre-existing pancreatic or gallbladder conditions, medications that interact with slowed gastric emptying, and whether your BMI and any weight-related conditions meet the licensed criteria. Men with a BMI of 30 or above, or 27 and above alongside a condition such as hypertension or high cholesterol, may be clinically suitable; the prescriber decides based on the full picture, not the number alone.
Dose increases follow a titration schedule (starting at 2.5mg and stepping up gradually) because most side effects are dose-dependent and moving slowly gives the body time to adapt. If side effects at a given dose are hard to manage, the prescriber may recommend holding at that level for longer rather than escalating. That decision belongs with a clinician, not a dosing schedule followed mechanically. Our clinical team reviews every consultation personally.
If you're considering treatment, the free consultation at nume is the starting point. Side effects, suitability, and your specific health context are all part of that conversation, our prescribers discuss all of it before anything is prescribed. Treatment is only dispensed where it's clinically appropriate.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.